151 related articles for article (PubMed ID: 27476422)
1. A new class of flavonol-based anti-prostate cancer agents: Design, synthesis, and evaluation in cell models.
Li X; Chen G; Zhang X; Zhang Q; Zheng S; Wang G; Chen QH
Bioorg Med Chem Lett; 2016 Sep; 26(17):4241-5. PubMed ID: 27476422
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship and pharmacokinetic studies of 3-O-substitutedflavonols as anti-prostate cancer agents.
Li X; Zhang C; Guo S; Rajaram P; Lee M; Chen G; Fong R; Gonzalez A; Zhang Q; Zheng S; Wang G; Chen QH
Eur J Med Chem; 2018 Sep; 157():978-993. PubMed ID: 30165345
[TBL] [Abstract][Full Text] [Related]
3. 3-O-Substituted-3',4',5'-trimethoxyflavonols: Synthesis and cell-based evaluation as anti-prostate cancer agents.
Li X; Lee M; Chen G; Zhang Q; Zheng S; Wang G; Chen QH
Bioorg Med Chem; 2017 Sep; 25(17):4768-4777. PubMed ID: 28760528
[TBL] [Abstract][Full Text] [Related]
4. Silibinin derivatives as anti-prostate cancer agents: Synthesis and cell-based evaluations.
Vue B; Zhang S; Zhang X; Parisis K; Zhang Q; Zheng S; Wang G; Chen QH
Eur J Med Chem; 2016 Feb; 109():36-46. PubMed ID: 26748997
[TBL] [Abstract][Full Text] [Related]
5. Nitrogen-containing derivatives of O-tetramethylquercetin: Synthesis and biological profiles in prostate cancer cell models.
Rajaram P; Jiang Z; Chen G; Rivera A; Phasakda A; Zhang Q; Zheng S; Wang G; Chen QH
Bioorg Chem; 2019 Jun; 87():227-239. PubMed ID: 30904813
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of novel flavonols as potential anti-prostate cancer agents.
Britton RG; Horner-Glister E; Pomenya OA; Smith EE; Denton R; Jenkins PR; Steward WP; Brown K; Gescher A; Sale S
Eur J Med Chem; 2012 Aug; 54():952-8. PubMed ID: 22789812
[TBL] [Abstract][Full Text] [Related]
7. 5- or/and 20-O-alkyl-2,3-dehydrosilybins: Synthesis and biological profiles on prostate cancer cell models.
Vue B; Zhang X; Lee T; Nair N; Zhang S; Chen G; Zhang Q; Zheng S; Wang G; Chen QH
Bioorg Med Chem; 2017 Sep; 25(17):4845-4854. PubMed ID: 28756013
[TBL] [Abstract][Full Text] [Related]
8. Superior anticancer activity of halogenated chalcones and flavonols over the natural flavonol quercetin.
Dias TA; Duarte CL; Lima CF; Proença MF; Pereira-Wilson C
Eur J Med Chem; 2013 Jul; 65():500-10. PubMed ID: 23771043
[TBL] [Abstract][Full Text] [Related]
9. 3-O-Alkyl-2,3-dehydrosilibinins: Two synthetic approaches and in vitro effects toward prostate cancer cells.
Zhang S; Vue B; Huang M; Zhang X; Lee T; Chen G; Zhang Q; Zheng S; Wang G; Chen QH
Bioorg Med Chem Lett; 2016 Jul; 26(14):3226-3231. PubMed ID: 27261177
[TBL] [Abstract][Full Text] [Related]
10.
Vue B; Zhang S; Vignau A; Chen G; Zhang X; Diaz W; Zhang Q; Zheng S; Wang G; Chen QH
Molecules; 2018 Nov; 23(12):. PubMed ID: 30501133
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, inverse docking-assisted identification and in vitro biological characterization of Flavonol-based analogs of fisetin as c-Kit, CDK2 and mTOR inhibitors against melanoma and non-melanoma skin cancers.
Roy T; Boateng ST; Banang-Mbeumi S; Singh PK; Basnet P; Chamcheu RN; Ladu F; Chauvin I; Spiegelman VS; Hill RA; Kousoulas KG; Nagalo BM; Walker AL; Fotie J; Murru S; Sechi M; Chamcheu JC
Bioorg Chem; 2021 Feb; 107():104595. PubMed ID: 33450548
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological evaluation of 1,9-diheteroarylnona-1,3,6,8-tetraen-5-ones as a new class of anti-prostate cancer agents.
Zhang X; Wang R; Perez GR; Chen G; Zhang Q; Zheng S; Wang G; Chen QH
Bioorg Med Chem; 2016 Oct; 24(19):4692-4700. PubMed ID: 27543391
[TBL] [Abstract][Full Text] [Related]
13. Antineoplastic activity of isoliquiritigenin, a chalcone compound, in androgen-independent human prostate cancer cells linked to G2/M cell cycle arrest and cell apoptosis.
Zhang B; Lai Y; Li Y; Shu N; Wang Z; Wang Y; Li Y; Chen Z
Eur J Pharmacol; 2018 Feb; 821():57-67. PubMed ID: 29277717
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of 1,7-diheteroarylhepta-1,4,6-trien-3-ones as curcumin-based anticancer agents.
Wang R; Zhang X; Chen C; Chen G; Zhong Q; Zhang Q; Zheng S; Wang G; Chen QH
Eur J Med Chem; 2016 Mar; 110():164-80. PubMed ID: 26827161
[TBL] [Abstract][Full Text] [Related]
15. Design and evaluation of novel oxadiazole derivatives as potential prostate cancer agents.
Mochona B; Qi X; Euynni S; Sikazwi D; Mateeva N; Soliman KF
Bioorg Med Chem Lett; 2016 Jun; 26(12):2847-2851. PubMed ID: 27156770
[TBL] [Abstract][Full Text] [Related]
16. Optimization of diarylpentadienones as chemotherapeutics for prostate cancer.
Patanapongpibul M; Zhang C; Chen G; Guo S; Zhang Q; Zheng S; Wang G; Chen QH
Bioorg Med Chem; 2018 Sep; 26(16):4751-4760. PubMed ID: 30121214
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and effects on cell viability of flavonols and 3-methyl ether derivatives on human leukemia cells.
Burmistrova O; Marrero MT; Estévez S; Welsch I; Brouard I; Quintana J; Estévez F
Eur J Med Chem; 2014 Sep; 84():30-41. PubMed ID: 25014747
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antitumor activity of novel 2-substituted indoline imidazolium salt derivatives.
Xu XL; Yu CL; Chen W; Li YC; Yang LJ; Li Y; Zhang HB; Yang XD
Org Biomol Chem; 2015 Feb; 13(5):1550-7. PubMed ID: 25491254
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and Anti-Proliferative Effects of Quercetin Derivatives.
Al-Jabban SM; Zhang X; Chen G; Mekuria EA; Rakotondraibe LH; Chen QH
Nat Prod Commun; 2015 Dec; 10(12):2113-8. PubMed ID: 26882678
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of novel 3-substituted 4-anilino-coumarin derivatives as antitumor agents.
Luo G; Muyaba M; Lyu W; Tang Z; Zhao R; Xu Q; You Q; Xiang H
Bioorg Med Chem Lett; 2017 Feb; 27(4):867-874. PubMed ID: 28110871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]